[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fmEvu94_5npxFlM3KrSd7lAKlcTUSFkOWz98lA7ti_Qw":8,"$fiWFNrBTuoVzvlbbr1uaqS0MRstm0A_mEYQQH_KFCmVY":55,"$f_3zoFRfMAKVfljyU3CucRIT9KxzNINcPF5sVtJ4r7AY":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},45987,870169,[],"https://cdn.yishi-tong.com/console/store-unknown/uF7OMd0P_hB1LaAPsAH23kXFsYY6stA4.png","丁传海","浙江定海医院（上海瑞金医院舟山分院）","肿瘤科","副主任医师",6,0,"紫杉醇、吉西他滨、伊立替康脂质体等胰腺恶性肿瘤药物使用指引","","https://ystcdn.venuertc.com/venue/AI/58fe4a40-4bd5-4e64-a318-3d6d4ed13e39.jpg","\u003Cdiv class=\"drug-guide-wrapper\">\n  \u003Ch2 id=\"material_title\" class=\"drug-guide-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">紫杉醇、吉西他滨、伊立替康脂质体等胰腺恶性肿瘤药物使用指引\u003C/h2>\n  \n  \u003Cdiv class=\"drug-guide-section drug-section-bg-1\">\n    \u003Ch2 class=\"drug-section-header\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 用药前必须了解：核心药物简介\u003C/h2>\n    \u003Cdiv class=\"drug-section-content\">\n      \u003Cp>\n        在胰腺恶性肿瘤的治疗中，紫杉醇（包括白蛋白结合型紫杉醇）、吉西他滨、以及伊立替康脂质体等药品被广泛应用于联合或单药方案。\u003Cbr>\n        \u003Cb>紫杉醇\u003C/b>是一类微管抑制剂，常见有普通型与白蛋白结合型注射剂；\u003Cb>吉西他滨\u003C/b>属于抗代谢类药物，通常以注射形式使用；\u003Cb>伊立替康脂质体\u003C/b>是改良型化疗药，以脂质体注射液为主。\u003Cbr>\n        这些药品在化疗方案中扮演着支柱角色，但每种药品的用法、相互作用和不良反应各不相同。本指引将详细分解7个关键用药细节，帮您科学、安全地用药。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"drug-guide-section drug-section-bg-2\">\n    \u003Ch2 class=\"drug-section-header\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 药理机制简述：它们如何发挥作用？\u003C/h2>\n    \u003Cdiv class=\"drug-section-content\">\n      \u003Cul>\n        \u003Cli>\u003Cb>紫杉醇/白蛋白结合型紫杉醇\u003C/b>：通过稳定微管结构，抑制细胞分裂。白蛋白型可提升药物到达肿瘤组织的效率，降低溶剂反应风险。\u003C/li>\n        \u003Cli>\u003Cb>吉西他滨\u003C/b>：为核苷类似物，掺入肿瘤细胞DNA后导致复制过程受阻，进而抑制细胞生长。\u003C/li>\n        \u003Cli>\u003Cb>伊立替康脂质体\u003C/b>：抑制拓扑异构酶I，阻断DNA修复与复制。脂质体包裹减少毒性、延长药物作用时间。\u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cspan class=\"drug-emoji\">💡\u003C/span> 药理机制决定了这些药物需严格监测血象及肝肾功能，用药前必须由专业医生评估以确定最适合的化疗搭配。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"drug-guide-section drug-section-bg-3\">\n    \u003Ch2 class=\"drug-section-header\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 正确用法用量：如何安全应用？\u003C/h2>\n    \u003Cdiv class=\"drug-section-content\">\n      \u003Cul>\n        \u003Cli>\u003Cb>紫杉醇/白蛋白结合型紫杉醇\u003C/b>：\n          \u003Cul>\n            \u003Cli>给药一般于 \u003Cb>静脉滴注\u003C/b>方式分周期进行（常见每周一次，也有每3周一次）。剂量通常与体表面积挂钩，由医生根据体重、耐受情况调整。\u003C/li>\n            \u003Cli>白蛋白结合型不需特殊预处理，普通紫杉醇常需服用预防过敏药。\u003C/li>\n          \u003C/ul>\n        \u003C/li>\n        \u003Cli>\u003Cb>吉西他滨\u003C/b>：\n          \u003Cul>\n            \u003Cli>通常采用静脉滴注，每周1-2次，分周期给药。按照体表面积换算剂量，周期按医生制定的方案执行。\u003C/li>\n          \u003C/ul>\n        \u003C/li>\n        \u003Cli>\u003Cb>伊立替康脂质体\u003C/b>：\n          \u003Cul>\n            \u003Cli>主要为二线治疗药物，静脉注射，每2-3周一次。剂量以体表面积为准，不同方案略有差异。\u003C/li>\n          \u003C/ul>\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cb>正确做法：\u003C/b>仅能由专业医师根据体检结果和方案具体执行，严禁擅自更改剂量和间隔。\n      \u003C/p>\n      \u003Cp>\n        案例分享：有位老年患者通过白蛋白结合型紫杉醇联合吉西他滨治疗，严格遵守医院制定的化疗周期，有效控制了副反应，提示规范执行方案十分关键。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"drug-guide-section drug-section-bg-4\">\n    \u003Ch2 class=\"drug-section-header\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 剂型、稀释与注射技巧\u003C/h2>\n    \u003Cdiv class=\"drug-section-content\">\n      \u003Cul>\n        \u003Cli>\u003Cb>紫杉醇\u003C/b>：\n          \u003Cul>\n            \u003Cli>注射液需先按照使用说明用特定溶剂稀释后滴注。\u003C/li>\n            \u003Cli>白蛋白结合型可直接稀释在生理盐水。\u003C/li>\n            \u003Cli>化疗期间滴注速度、总液量均须遵照医生指示，避免溶液配比错误。\u003C/li>\n          \u003C/ul>\n        \u003C/li>\n        \u003Cli>\u003Cb>吉西他滨\u003C/b>：\n          \u003Cul>\n            \u003Cli>冻干粉剂，必须由医护人员用无菌水溶解再注入静脉。\u003C/li>\n            \u003Cli>注射期间应持续观察，防止静脉炎。\u003C/li>\n          \u003C/ul>\n        \u003C/li>\n        \u003Cli>\u003Cb>伊立替康脂质体\u003C/b>：\n          \u003Cul>\n            \u003Cli>为脂质体包裹型注射剂，使用方法需与常规伊立替康区分，通常以较低速度输注。\u003C/li>\n          \u003C/ul>\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cspan class=\"drug-emoji\">🔬\u003C/span> 使用过程中，溶剂、用量、滴注速率等应严格交由专业人员操作。如有沉淀、变色等情况，严禁使用。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"drug-guide-section drug-section-bg-5\">\n    \u003Ch2 class=\"drug-section-header\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 主要不良反应与处理方法\u003C/h2>\n    \u003Cdiv class=\"drug-section-content\">\n      \u003Cp>\n        这三类药物因其强烈细胞毒性，副作用普遍，但有规律可循。\n      \u003C/p>\n      \u003Cul>\n        \u003Cli>\u003Cb>紫杉醇及白蛋白结合型紫杉醇\u003C/b>：\n          \u003Cul>\n            \u003Cli>常见：发热、白细胞减少、周围神经麻木、脱发等。\u003C/li>\n            \u003Cli>偶有过敏反应，普通型风险更高。出现呼吸异常、面部潮红应立即停药并处理。\u003C/li>\n          \u003C/ul>\n        \u003C/li>\n        \u003Cli>\u003Cb>吉西他滨\u003C/b>：\n          \u003Cul>\n            \u003Cli>常见：白细胞、血小板减少，肝酶升高。\u003C/li>\n            \u003Cli>个别患者可见肾损伤、皮疹。\u003C/li>\n          \u003C/ul>\n        \u003C/li>\n        \u003Cli>\u003Cb>伊立替康脂质体\u003C/b>：\n          \u003Cul>\n            \u003Cli>常见：腹泻（可能为早发型或迟发型）、白细胞下降。\u003C/li>\n            \u003Cli>有个别可能出现较重的中性粒细胞减少症。\u003C/li>\n          \u003C/ul>\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cb>正确做法：\u003C/b>用药期间应定期进行血常规、肝肾功能监测。有腹泻、中性粒细胞下降或过敏等表现应立即就医评估。说明书表明，伊立替康相关腹泻发生率超50%，需高度关注缓解措施 \u003Cspan class=\"drug-emoji\">⚠️\u003C/span>。\u003Cbr>\n        \u003Cspan class=\"drug-tip-text\">注：副作用因人而异。极少数个体可发生严重过敏或骨髓抑制。\u003C/span>\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"drug-guide-section drug-section-bg-6\">\n    \u003Ch2 class=\"drug-section-header\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 药物相互作用：需要避开的用药组合\u003C/h2>\n    \u003Cdiv class=\"drug-section-content\">\n      \u003Cul>\n        \u003Cli>\u003Cb>紫杉醇类\u003C/b>：\n          \u003Cul>\n            \u003Cli>应避免与已知肝酶抑制剂或诱导剂（如某些抗生素、抗真菌药）同时使用，否则可能影响代谢、增强毒性。\u003C/li>\n            \u003Cli>避免与地尔硫䓬、维拉帕米同服。\u003C/li>\n          \u003C/ul>\n        \u003C/li>\n        \u003Cli>\u003Cb>吉西他滨\u003C/b>：\n          \u003Cul>\n            \u003Cli>不宜与氟尿嘧啶同天使用，以减少加重骨髓抑制。\u003C/li>\n            \u003Cli>应与注射人白蛋白等蛋白类制剂间隔半小时以上。\u003C/li>\n          \u003C/ul>\n        \u003C/li>\n        \u003Cli>\u003Cb>伊立替康脂质体\u003C/b>：\n          \u003Cul>\n            \u003Cli>与酶抑制药（如酮康唑、环孢素）联用时药物代谢减慢，毒副反应风险增加。\u003C/li>\n            \u003Cli>不建议与苯妥英等肝酶诱导剂合用。\u003C/li>\n          \u003C/ul>\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        正确做法：告知医生近期所有用药、保健品，包括中草药。每种新药需征询主诊医生，以防相互作用。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"drug-guide-section drug-section-bg-7\">\n    \u003Ch2 class=\"drug-section-header\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 特殊人群、过敏史与禁忌症\u003C/h2>\n    \u003Cdiv class=\"drug-section-content\">\n      \u003Cul>\n        \u003Cli>\u003Cb>过敏史\u003C/b>：\n          \u003Cul>\n            \u003Cli>青霉素、头孢等抗生素过敏史不一定意味着对紫杉醇、吉西他滨、伊立替康脂质体过敏，但有药物综合过敏者需加倍警惕。\u003C/li>\n            \u003Cli>普通型紫杉醇应避免用于对蓖麻油等辅料高度敏感者。\u003C/li>\n          \u003C/ul>\n        \u003C/li>\n        \u003Cli>\u003Cb>特殊人群\u003C/b>：\n          \u003Cul>\n            \u003Cli>肝肾功能异常者：剂量需大幅调整，严重者禁用。\u003C/li>\n            \u003Cli>孕妇/哺乳期：禁用。\u003C/li>\n            \u003Cli>老年患者：根据身体状况个体化减量。\u003C/li>\n            \u003Cli>患有严重白细胞减少、血小板减少者禁用。\u003C/li>\n          \u003C/ul>\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cb>特别提醒：\u003C/b>既往严重不良反应或过敏史患者，首次化疗应密切监测，部分药品可进行皮试。每次用药前需主动向医生说明过敏情况。\n      \u003C/p>\n      \u003Cp>\n        案例提示：一位女性患者既往青霉素过敏，在使用白蛋白结合型紫杉醇前主动告知过敏史，成功避开不合适方案，确保了整体治疗安全。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"drug-guide-section drug-section-bg-8\">\n    \u003Ch2 class=\"drug-section-header\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08 储存与携带要求\u003C/h2>\n    \u003Cdiv class=\"drug-section-content\">\n      \u003Cul>\n        \u003Cli>\u003Cb>紫杉醇及白蛋白结合型\u003C/b>：需密闭、避光，2-8℃冷藏，不允许冷冻，也不应反复打开和转移容器。\u003C/li>\n        \u003Cli>\u003Cb>吉西他滨冻干粉\u003C/b>：需贮存在阴凉干燥处（一般2-8℃），稀释后立即使用，不宜放置超过24小时。\u003C/li>\n        \u003Cli>\u003Cb>伊立替康脂质体\u003C/b>：保存于2-8℃，同样不应冻结或阳光直射。\u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cb>正确做法：\u003C/b>家庭自备部分药品时，须带回医院低温冷链，家中冰箱专用分区存放，远离儿童。过期或已稀释药品切勿自行使用。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"drug-guide-section drug-section-bg-9\">\n    \u003Ch2 class=\"drug-section-header\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">09 忘服与用药过量处理\u003C/h2>\n    \u003Cdiv class=\"drug-section-content\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cb>遗忘一次化疗剂量\u003C/b>：需尽快联系主诊医生，不应自行补用。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>化疗药过量\u003C/b>：可迅速出现严重骨髓抑制、肝肾损伤等，应送医院紧急处理。自救无效。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cspan class=\"drug-emoji\">🚑\u003C/span> 关键建议：“化疗药品任何剂量失误，都要第一时间就医。”\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"drug-guide-section drug-section-bg-10\">\n    \u003Ch2 class=\"drug-section-header\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">10 用药案例经验汇总表\u003C/h2>\n    \u003Cdiv class=\"drug-section-content\">\n      \u003Cul>\n        \u003Cli>有患者在白蛋白结合型紫杉醇及吉西他滨联用期间规范分周期、按时监测血象，整体副作用较轻，疗程顺利，提示方案规范极为重要。\u003C/li>\n        \u003Cli>化疗期间同时服用中药未提前沟通，导致药物相互作用增加副反应风险，由此提醒所有患者联合用药务必提前报备。\u003C/li>\n        \u003Cli>一位高龄女性在化疗中出现骨髓抑制，调整剂量、延长间隔后安全继续下去，显示个体化调整能带来更佳耐受性。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"drug-guide-section drug-section-bg-summary\">\n    \u003Ch2 class=\"drug-section-header\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">结语与安全用药提示\u003C/h2>\n    \u003Cdiv class=\"drug-section-content\">\n      \u003Cp>\n        紫杉醇、吉西他滨、伊立替康脂质体等化疗药品强效但风险较高，只有在专业团队指导下严格按照规定用药，才可保障安全与疗效。尤其在周期、剂量、并用药品、血象监测、不良反应处理等方面，任何疑问都要及时与医生沟通。一切化疗相关用药，自行更改都可能带来不可逆后果。必要时随身携带过敏史和用药明细，便于急救处置。\n      \u003C/p>\n      \u003Cp>\n        这些细节决定着治疗的安全界限。记住：疑则问、不自作主张、不隐瞒新旧用药信息，是每位用药者的最大保障。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"drug-refer-section\">\n    \u003Ch3 class=\"drug-refer-header\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献\u003C/h3>\n    \u003Cul class=\"drug-refer-list\">\n      \u003Cli>\n        Adamska, A., Domenichini, A., & Falasca, M. (2017). Pancreatic ductal adenocarcinoma: current and evolving therapies. International Journal of Molecular Sciences, 18(7), 1338. \u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/28671652/\" target=\"_blank\">[PubMed]\u003C/a>\n      \u003C/li>\n      \u003Cli>\n        Von Hoff, D. D., Ervin, T., Arena, F. P., Chiorean, E. G., Infante, J., Moore, M., ... & Renschler, M. F. (2013). Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. New England Journal of Medicine, 369(18), 1691-1703. \u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/24131140/\" target=\"_blank\">[PubMed]\u003C/a>\n      \u003C/li>\n      \u003Cli>\n        Wang, F., & Xu, R. (2023). Liposomal irinotecan in pancreatic cancer: current status and future directions. Cancers, 15(4), 1092. \u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/36837328/\" target=\"_blank\">[PubMed]\u003C/a>\n      \u003C/li>\n      \u003Cli>\n        Heinemann, V. (2002). Gemcitabine plus cisplatin as chemotherapy of pancreatic cancer. Cancer, 95(5), 933-940. \u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/12209605/\" target=\"_blank\">[PubMed]\u003C/a>\n      \u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\u003C/div>\n\u003Cstyle>\n.drug-guide-wrapper {\n  font-family: 'Helvetica Neue', Arial, 'PingFang SC', 'Segoe UI', sans-serif;\n  color: #222f36;\n  background: #f5f8fa;\n  padding: 32px 18px 72px 18px;\n  max-width: 840px;\n  margin: 34px auto 60px auto;\n  border-radius: 18px;\n  box-shadow: 0 4px 24px rgba(40,90,110,0.09);\n  box-sizing: border-box;\n}\n.drug-guide-title {\n  text-align: center;\n  font-size: 32px;\n  color: #214155;\n  font-weight: 700;\n  margin-bottom: 40px;\n  letter-spacing: 1px;\n  background: linear-gradient(90deg, #e2f0ff 0%, #fdfbfb 100%);\n  padding: 22px 0 18px 0;\n  border-radius: 10px;\n  box-shadow: 0 2px 12px rgba(80,170,220,0.06);\n}\n.drug-guide-section {\n  margin-bottom: 36px;\n  border-radius: 13px;\n  box-shadow: 0 2px 16px rgba(43,82,95,0.06);\n  background: #fff;\n  padding: 0 0 0 0;\n  transition: box-shadow .22s;\n}\n.drug-section-header {\n  font-size: 22px;\n  font-weight: 600;\n  color: #30608a;\n  border-radius: 13px 13px 0 0;\n  margin: 0;\n  padding: 22px 18px 12px 28px;\n  letter-spacing: .5px;\n  background-repeat: no-repeat;\n  background-size: cover;\n  position: relative;\n}\n.drug-section-bg-1 .drug-section-header {\n  background: linear-gradient(90deg, #ecf4ff 20%, #e0f6ed 100%);\n}\n.drug-section-bg-2 .drug-section-header {\n  background: linear-gradient(90deg, #f9efed 30%, #e4f8f0 100%);\n}\n.drug-section-bg-3 .drug-section-header {\n  background: linear-gradient(90deg, #e5ffe7 0%, #e5f2fc 100%);\n}\n.drug-section-bg-4 .drug-section-header {\n  background: linear-gradient(90deg, #e9ecfa 10%, #e7ffee 100%);\n}\n.drug-section-bg-5 .drug-section-header {\n  background: linear-gradient(90deg, #ffe6ef 10%, #f5fae6 100%);\n}\n.drug-section-bg-6 .drug-section-header {\n  background: linear-gradient(90deg, #f2e0fa 20%, #f6fff8 100%);\n}\n.drug-section-bg-7 .drug-section-header {\n  background: linear-gradient(90deg, #e4e8fc 5%, #fcffe6 100%);\n}\n.drug-section-bg-8 .drug-section-header {\n  background: linear-gradient(90deg, #eefdff 15%, #fceee6 100%);\n}\n.drug-section-bg-9 .drug-section-header {\n  background: linear-gradient(90deg, #fffbe6 0%, #e6faff 100%);\n}\n.drug-section-bg-10 .drug-section-header {\n  background: linear-gradient(90deg, #f5f5fa 20%, #e6fff6 100%);\n}\n.drug-section-bg-summary .drug-section-header {\n  background: linear-gradient(90deg, #e0f2ec 10%, #fff5f0 100%);\n}\n.drug-section-content {\n  font-size: 17px;\n  padding: 20px 32px 22px 32px;\n  background: rgba(244,250,253,0.87);\n  border-radius: 0 0 13px 13px;\n  margin-bottom: 0;\n  line-height: 1.92;\n}\n.drug-section-content ul {\n  padding-left: 22px;\n  margin: 0 0 10px 0;\n}\n.drug-section-content ul  li {\n  margin-bottom: 8px;\n}\n.drug-emoji {\n  font-size: 22px;\n  vertical-align: middle;\n}\n.drug-tip-text {\n  color: #d49300;\n  font-size: 16px;\n  font-weight: 500;\n  padding-left: 6px;\n}\n.drug-refer-section {\n  margin: 54px 0 18px 0;\n  padding: 24px 24px 18px 24px;\n  background: #f6fbfa;\n  border-radius: 10px;\n  box-shadow: 0 1px 9px rgba(65,155,180,0.13);\n}\n.drug-refer-header {\n  font-size: 19px;\n  font-weight: 600;\n  color: #339;\n  margin-bottom: 10px;\n}\n.drug-refer-list {\n  padding-left: 22px;\n  margin: 0;\n  font-size: 16px;\n}\n.drug-refer-list li {\n  margin-bottom: 8px;\n  line-height: 1.7;\n}\n@media (max-width: 670px) {\n  .drug-guide-wrapper {\n    padding: 13px 4px 48px 4px;\n    max-width: 100%;\n  }\n  .drug-section-content {\n    padding: 14px 10px 15px 10px;\n    font-size: 15px;\n  }\n  .drug-refer-section {\n    padding: 14px 8px 10px 8px;\n    font-size: 14px;\n  }\n  .drug-guide-title {\n    font-size: 22px;\n    padding: 10px 0 9px 0;\n  }\n}\n\u003C/style>\n","\u003Cdiv class=\"drug-guide-wrapper\">\n  \u003Ch2 id=\"material_title\" class=\"drug-guide-title\" style=\"color: rg",535,"2025-07-03 10:26:03","胰腺恶性肿瘤, 紫杉醇, 吉西他滨, 伊立替康脂质体, 化疗药物, 不良反应, 用药指南, 医疗安全","了解紫杉醇、吉西他滨、伊立替康脂质体等胰腺癌化疗药物的用法、药理机制及不良反应，帮助患者安全用药与自我管理！","2025-07-07 11:26:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]